Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Nature Reviews. Drug Discovery|May 19, 2026
Realizing the potential of agonistic antibody immunotherapyMark S Cragg, Xiaojie Yu, Christopher Paluch, et al.Frontiers in Immunology|October 24, 2018
Immune Checkpoints as Therapeutic Targets in AutoimmunityChristopher Paluch, Ana Mafalda Santos, Consuelo Anzilotti, et al.Immunotherapy Advances|April 21, 2023
Combination CD200R/PD-1 blockade in a humanised mouse modelMartin Fellermeyer, Consuelo Anzilotti, Christopher Paluch, et al.Genome Medicine|July 16, 2026
A map of intra- and intercellular immune responses across diverse in vitro stimuli and inflammatory diseaseOliver Wood, Adam T Braithwaite, Josephine Fisher, et al.Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.Oncotarget|May 24, 2017
Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activationSofia Nascimento Dos Santos, Helen Sheldon, Jonathas Xavier Pereira, et al.Scientific Reports|August 28, 2024
Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitisJoel Quinn, Ahmed Salman, Christopher Paluch, et al.Nature Immunology|August 23, 2022
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulationAlan Kennedy, Erin Waters, Behzad Rowshanravan, et al.Immunity|February 14, 2024
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatasesAnna H Lippert, Christopher Paluch, Meike Gaglioni, et al.Pageof 1